Myriad Pharmaceuticals Private Limited

Myriad Pharmaceuticals Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100MH2011PTC221866 Incorporated 11 September 2011 ROC Mumbai HQ Nagpur, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹52.03 Lakh
▲ 10% YoY
Net profit · FY 2025
₹1.36 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹3.19 Lakh
EBITDA margin 6.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
6
As per MCA filings
Active GSTINs
1
GST registered

About Myriad Pharmaceuticals Private Limited

Data last updated:

Myriad Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 September 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2011PTC221866. Its GSTIN is 27AAHCM4281D1ZI (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Dhanraj Kashinath Mohod and Govinda Mohod.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 96 Orange Nagar Near Kharbi Chowk, Nagpur, Maharashtra, India – 440008.

As per the financials filed for FY 2025, the company reported a revenue of ₹52.03 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.36 Lakh (net margin 2.6%) and EBITDA of ₹3.19 Lakh (EBITDA margin 6.1%). Revenue has grown at a compounded annual rate (CAGR) of 41% over five years.

Court records list 1 case involving the company, including 1 filed against it.

Myriad Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0023805). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24100MH2011PTC221866
Registration Number 221866
Incorporation Date 11 September 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0023805
Key People
Dhanraj Kashinath Mohod Director Govinda Mohod Director Snehal Sachin Sonkusare Director

Recognitions & Rankings of Myriad Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-20-0023805

Contact details

Myriad Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. 96 Orange Nagar Near Kharbi Chowk, Nagpur, Maharashtra, India – 440008
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Myriad Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Myriad Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Myriad Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Myriad Pharmaceuticals Private Limited, buy the company report.

Financials of Myriad Pharmaceuticals Private Limited

FY 2025 filings available

Myriad Pharmaceuticals Private Limited reported revenue of ₹52.03 Lakh (up 10% YoY) for FY 2025.

Revenue · FY 2025
₹52.03 Lakh ▲ 10%
Net profit · FY 2025
₹1.36 Lakh margin 2.6%
EBITDA · FY 2025
₹3.19 Lakh margin 6.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
5 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 15%
5 years · compounded
▲ 77%

Revenue has grown at a compounded annual rate (CAGR) of 41% over five years, including 10% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.19 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.36 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.1%
Net Profit Margin2.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Myriad Pharmaceuticals Private Limited, buy the company report.

Board of directors of Myriad Pharmaceuticals Private Limited

Myriad Pharmaceuticals has 6 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Dhanraj Kashinath MohodDirector11 Sep 201115 Years 1 MonthsCurrent
Govinda MohodDirector11 Sep 201115 Years 1 MonthsCurrent
Snehal Sachin SonkusareDirector08 Feb 20206 Years 8 MonthsCurrent
Ashish Pandurang PrachandDirector10 Nov 20205 Years 11 MonthsCurrent
Pralhad Harinarayan SharmaDirector10 Nov 20205 Years 11 MonthsCurrent
Khushbu Hemant WaghmareDirector05 May 20251 Years 5 MonthsCurrent
View all directors

Peer comparison

Myriad Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Hawksbill Pharmaceuticals Private Limited₹52.1 Lakh (FY 2025)9.0%Ahmedabad, Gujarat, India
Prochem Bioceuticals Private Limited₹52.07 Lakh (FY 2025)-13.0%Delhi, India
Myriad Pharmaceuticals Private Limitedthis company₹52.03 Lakh (FY 2025)₹1.36 Lakh2.6%10.0%Nagpur, Maharashtra, India
Bioziv Healthcare Private Limited₹51.99 Lakh (FY 2024)-23.0%Manimajra, Chandigarh, India
Novomax Pharma Private Limited₹51.88 Lakh (FY 2024)90.0%New Delhi, Delhi, India

To see the full peer comparison of Myriad Pharmaceuticals Private Limited, buy the company report.

Auditor

Myriad Pharmaceuticals Private Limited is audited by Lohakare Raja & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Lohakare Raja & Co.FY 2023122684W

Shareholding

The shareholding of Myriad Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Myriad Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Myriad Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Myriad Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAHCM4281D1ZIMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Myriad Pharmaceuticals Private Limited, buy the company report.

Recent activity

Myriad Pharmaceuticals Private Limited has 6 board changes on record since 2011: 6 appointments. The latest: Khushbu Hemant Waghmare was appointed as Director on 05 May 2025.

AGM
Myriad Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Khushbu Hemant Waghmare was appointed as Director.
Filing
Myriad Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Ashish Pandurang Prachand was appointed as Director.
Appointed
Pralhad Harinarayan Sharma was appointed as Director.
Appointed
Snehal Sachin Sonkusare was appointed as Director.
Appointed
Dhanraj Kashinath Mohod was appointed as Director.
Appointed
Govinda Mohod was appointed as Director.
Incorporation
11 Sep 2011
Myriad Pharmaceuticals Private Limited was registered on 11 Sep 2011 with Roc Mumbai & aged 15 years 1 month as per MCA records.

Frequently asked questions

Myriad Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 September 2011 (15+ years old) and is registered under CIN U24100MH2011PTC221866.

Myriad Pharmaceuticals has 6 current directors:

The latest financial statements of Myriad Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Myriad Pharmaceuticals is 27AAHCM4281D1ZI, registered in Maharashtra.

The CIN (Corporate Identification Number) of Myriad Pharmaceuticals is U24100MH2011PTC221866. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Myriad Pharmaceuticals has 1 court case on record: 1 filed against it.

Myriad Pharmaceuticals was incorporated on 11 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Myriad Pharmaceuticals by revenue are Hawksbill Pharmaceuticals Private Limited, Prochem Bioceuticals Private Limited, Bioziv Healthcare Private Limited, Novomax Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Khushbu Hemant Waghmare was appointed as Director on 05 May 2025. Ashish Pandurang Prachand was appointed as Director on 10 Nov 2020. Pralhad Harinarayan Sharma was appointed as Director on 10 Nov 2020. Myriad Pharmaceuticals has 6 board changes on record in total.

Yes, Myriad Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0023805).

The registered office of Myriad Pharmaceuticals is at Plot No. 96 Orange Nagar Near Kharbi Chowk, Nagpur, Maharashtra, India – 440008.